[{"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LOSARTAN POTASSIUM, Tablet, 25 mg may have potentially been mislabeled as the following drug:  PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: AD46312_22, EXP: 4/30/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "LOSARTAN POTASSIUM, Tablet, 25 mg has the following codes:   Pedigree: AD46312_16, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LOSARTAN POTASSIUM, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093736498.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-844-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ASPIRIN, Tablet, 325 mg may have potentially been mislabeled as one of the following drugs:  PANCRELIPASE DR, Capsule, 0 mg, NDC 42865010302, Pedigree: W003354, EXP: 6/19/2014;  acetaZOLAMIDE, Tablet, 250 mg, NDC 51672402301, Pedigree: W003524, EXP: 6/21/2014;  METOPROLOL TARTRATE, Tablet, 25 mg, NDC 00378001801, Pedigree: W002535, EXP: 6/3/2014;  RIVAROXABAN, Tablet, 20 mg,", "address_2": "", "product_quantity": "900 Tablets", "code_info": "ASPIRIN, Tablet, 325 mg has the following codes:   Pedigree: W003355, EXP: 6/19/2014;  Pedigree: W003525, EXP: 6/21/2014;  Pedigree: W002573, EXP: 6/3/2014;  Pedigree: W002624, EXP: 6/4/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536330501.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-928-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0261-2015", "product_description": "Tri-Mix (PGE-10MCG/PAP-30MG/PT 5Ml vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-5123-09", "product_quantity": "17 vials", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141008BB, 11/8/14; 141008CC, 11/8/14; 141010G, 11/10/14; 141010J, 11/10/14; 141010K, 11/10/14; 141013GG, 11/13/14; 141015DD, 11/15/14; 141015BB, 11/15/14; 141020GG, 11/20/14; 141024HH, 11/24/14; 141024II, 11/24/14; 141024JJ, 11/24/14; 141028BB, 11/28/14; 141028CC, 11/28/14; 141031GG, 12/1/14;", "more_code_info": ""}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "", "code_info": "Lot #: 10116030, Exp 6/30/2013.    Korea product: 10112972, Exp 5/31/2013 and 10116032, Exp 7/31/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "NeoCitran Extra Strength Non-Drowsy Cold & Sinus (acetaminophen 650 mg and phenylephrine hydrochloride 10 mg) powder packets, Natural Source Lemon flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, UPC 0 58478 05703 3.    Also packaged under foreign label: Theraflu Daytime Severe Cold powder packets, Natural Lemon flavor, 6-count packets per carton, Novartis Consumer Health, Inc., Parsippany, NJ 07054-0622, NDC 0067-7116-06, UPC 8 806536 01402 1 (Korea Product)", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-761-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0199-2015", "product_description": "HYDROXOCOBALAMIN- preservative (B12), 1mg/mL, injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "570 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140729@18, discard date: 10/27/2014"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67399", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1084-2014", "product_description": "Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle, Rx only, Distributed by Mylan Pharmaceuticals Inc. Morgantown, WV 26505, NDC 0378-1819-01", "product_quantity": "138,970 bottles", "reason_for_recall": "Subpotent Drug: Assay results obtained during stability testing for Levothyroxine Sodium Tablets, USP were below specification.", "recall_initiation_date": "20140114", "center_classification_date": "20140210", "termination_date": "20151014", "report_date": "20140219", "code_info": "Lot 3037531 EXP 03/14  Lot 3038284 EXP 04/14"}, {"status": "Terminated", "city": "Sanford", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67420", "recalling_firm": "Hill Dermaceuticals, Inc.", "address_1": "2650 S Mellonville Ave", "address_2": "N/A", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1174-2014", "product_description": "Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical Oil (Scalp Oil), 4 fl. oz., Rx only.  Manufactured and Distributed by: Hill Dermaceuticals, Inc. Sanford, Florida 32773 NDC 28105-149-04", "product_quantity": "14,226 bottles", "reason_for_recall": "Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.", "recall_initiation_date": "20140131", "center_classification_date": "20140324", "termination_date": "20150203", "report_date": "20140402", "code_info": "12J030C exp. 03/14, 12L041C exp. 05/14"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DOXYCYCLINE HYCLATE, Capsule, 100 mg may have potentially been mislabeled as the following drug:  RALOXIFENE HCL, Tablet, 60 mg, NDC 00002416530, Pedigree: W002644, EXP: 6/5/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "DOXYCYCLINE HYCLATE, Capsule, 100 mg has the following codes:   Pedigree: W002645, EXP: 6/5/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOXYCYCLINE HYCLATE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143314250.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-867-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1211-2014", "product_description": "Pleo Ex PORTABLE SIPS 5X, 10 x 1 mL, Oral Homeopathic Medicine, OTC Only.  Made in Germany.  Distributed by: SANUM USA Corp. 1465 Slator Road, Ferndale, WA 98248. Manufactured by: Sanum-Kehlbeck GmbH & Co. KG,  NDC: 49807-1005-1.     PLEO--EX Portable Sips 5X, 50 x 1 mL, Oral Homeopathic Medicine, OTC Only.  Made in Germany.  Distributed by: SANUM USA Corp. 1465 Slator Road, Ferndale, WA 98248. Manufactured by: Sanum-Kehlbeck GmbH & Co. KG,  NDC: 49807-1005-2.", "product_quantity": "111 10 x 1 mls; 39  50 x 1 mls", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "10 x 1 mL: Batch # 09020; EXP: January 2015; Batch # 03052, EXP: April 2017.  50 x 1 mL: Batch # 09020; EXP: January 2015; Batch # 03052, EXP: April 2017."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MESALAMINE DR, Capsule, 400 mg may have potentially been mislabeled as the following drug:    CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg, NDC 11868000901, Pedigree: AD34928_1, EXP: 5/9/2014.", "address_2": "", "product_quantity": "180 Capsules", "code_info": "MESALAMINE DR, Capsule, 400 mg has the following codes:   Pedigree: AD34934_1, EXP: 1/31/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MESALAMINE DR, Capsule, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00430075327.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-912-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx 28314 Exp 5/22/2014", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Desferal 2.5 gm/14 mL Sterile Water, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, Rx # 28314, Discard After 05/22/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1456-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg may be potentially mislabeled as    ACETAMINOPHEN, CHEW Tablet, 80 mg, NDC 00536323307, Pedigree: AD49399_1, EXP: 5/16/2014;  LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD46300_11, EXP: 5/15/2014;  MYCOPHENOLATE MOFETIL, Capsule, 250 mg, NDC 00781206701, Pedigree: AD65457_7, EXP: 5/24/2014.", "address_2": "", "product_quantity": "294 Capsules", "code_info": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg has the following codes    Pedigree: AD49399_4, EXP: 5/16/2014;  Pedigree: AD46300_17, EXP: 5/15/2014;  Pedigree: AD65457_22, EXP: 5/24/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-502-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; VITAMIN B COMPLEX W/C Capsule may be potentially mislabeled as    SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD39560_1, EXP: 5/13/2014.", "address_2": "", "product_quantity": "2,398 Capsules", "code_info": "VITAMIN B COMPLEX W/C, Capsule has the following code    Pedigree: AD39560_4, EXP: 5/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VITAMIN B COMPLEX W/C Capsule, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 54629008001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-617-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69494", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and U.S. Virgin Islands.", "recall_number": "D-0284-2015", "product_description": "Normosol-R Multiple Electrolytes Injection Type 1, USP, 1000 mL container,  Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7967-09.", "product_quantity": "305,664 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.", "recall_initiation_date": "20141014", "center_classification_date": "20141125", "termination_date": "20151228", "report_date": "20141203", "code_info": "Lot # 32-081-JT; Exp. 08/15  Lot # 34-115-JT; Exp. 10/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; CYPROHEPTADINE HCL Tablet, 4 mg may be potentially mislabeled as    ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: W003673, EXP: 6/25/2014;  AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: W003323, EXP: 6/18/2014.", "address_2": "", "product_quantity": "203 Tablets", "code_info": "CYPROHEPTADINE HCL, Tablet, 4 mg has the following codes    Pedigree: W003676, EXP: 6/25/2014;  Pedigree: W003324, EXP: 6/18/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CYPROHEPTADINE HCL Tablet, 4 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60258085001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-655-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; traMADol HCl Tablet, 25 mg (1/2 of 50 mg) may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 137 mcg, NDC 00527163801, Pedigree: AD60272_76, EXP: 5/22/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "traMADol HCl, Tablet, 25 mg (1/2 of 50 mg) has the following code    Pedigree: AD60272_92, EXP: 5/22/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "traMADol HCl Tablet, 25 mg (1/2 of 50 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 57664037708", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-626-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toms River", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67810", "recalling_firm": "Pure Edge Nutrition", "address_1": "1182 Fischer Blvd Ste 3", "address_2": "N/A", "postal_code": "08753-3093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1367-2014", "product_description": "Bella Vi BTrim ULTIMATE BOOST Dietary Supplement capsules, 30 count bottles, www.BellaViProducts.com, distributed by Pure Edge Nutrition, LLC, Toms River, NJ", "product_quantity": "unknown", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein", "recall_initiation_date": "20131010", "center_classification_date": "20140612", "termination_date": "20161007", "report_date": "20140618", "code_info": "lot # BTRM3452 EXP: 2015/07/03"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL Chew Tablet may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD30140_40, EXP: 5/7/2014;  LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU, NDC 43292050022, Pedigree: AD30028_10, EXP: 5/7/2014.", "address_2": "", "product_quantity": "180 Chew Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL, Chew Tablet has the following codes    Pedigree: AD30180_10, EXP: 5/9/2014;  Pedigree: AD32325_1, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL Chew Tablet, Over The Counter, Distributed by: AidaPak Service, LLC,  NDC 58914001460", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-638-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deltona", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67471", "recalling_firm": "MyNicNaxs, Inc.", "address_1": "1012 Alpine Dr", "address_2": "N/A", "postal_code": "32725-7204", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1374-2014", "product_description": "Super Fat Burning Bomb Capsules, 400 mg, supplied in 30 count boxes, distributed by MyNicKnaxs, LLC, Deltona, FL", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Phenolphthalein and N-desmethylsibutramine", "recall_initiation_date": "20140124", "center_classification_date": "20140612", "termination_date": "20191002", "report_date": "20140618", "code_info": "ALL LOTS"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; TORSEMIDE, Tablet, 10 mg may be potentially mislabeled as    PYRIDOXINE HCL, Tablet, 50 mg, NDC 00536440801, Pedigree: AD30197_22, EXP: 5/9/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "TORSEMIDE, Tablet, 10 mg has the following code    Pedigree: AD30197_25, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TORSEMIDE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111091601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-595-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0162-2015", "product_description": "Tri-mix T102, 17.65 mg/0.59 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08192014@18, Exp 11/17/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040327"], "brand_name": ["ORPHENADRINE CITRATE"], "generic_name": ["ORPHENADRINE CITRATE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0185-0022"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ORPHENADRINE CITRATE"], "rxcui": ["994521"], "spl_id": ["de0e8cdb-788a-4ebe-969d-14d44a14ddc2"], "spl_set_id": ["239018ff-cec6-46de-ae9d-26c9ec034a32"], "package_ndc": ["0185-0022-10", "0185-0022-01"], "is_original_packager": [true], "unii": ["X0A40N8I4S"]}, "product_type": "Drugs", "event_id": "68860", "recalling_firm": "Sandoz Inc", "address_1": "506 Carnegie Ctr", "address_2": "", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1445-2014", "product_description": "Orphenadrine Citrate Extended Release Tablets, 100 mg  a)100-count bottle,  (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.", "product_quantity": "781,000 extended release tablets", "reason_for_recall": "Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.", "recall_initiation_date": "20140711", "center_classification_date": "20140723", "termination_date": "20170710", "report_date": "20140730", "code_info": "Lot # DM1316; Exp.  05/16  Lot # DM1318; Exp.  05/16", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: amLODIPine BESYLATE, Tablet, 5 mg may have potentially been mislabeled as the following drug:  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: W002839, EXP: 6/7/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "amLODIPine BESYLATE, Tablet, 5 mg has the following codes:   Pedigree: W002840, EXP: 6/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "amLODIPine BESYLATE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093716798.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-843-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; hydrALAZINE HCl Tablet, 50 mg may be potentially mislabeled as    CapsuleTOPRIL, Tablet, 12.5 mg, NDC 00143117101, Pedigree: AD52778_16, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "hydrALAZINE HCl, Tablet, 50 mg has the following code    Pedigree: AD52778_28, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "hydrALAZINE HCl Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111032801", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-591-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sandpoint", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68222", "recalling_firm": "Thorne Research Inc", "address_1": "25820 Hwy 2 West", "address_2": "N/A", "postal_code": "83864", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Visit", "distribution_pattern": "Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.", "recall_number": "D-1383-2014", "product_description": "Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 74002 5", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.", "recall_initiation_date": "20140612", "center_classification_date": "20140613", "termination_date": "20141015", "report_date": "20140625", "code_info": "All lot codes", "more_code_info": ""}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.", "address_2": "", "product_quantity": "5812 bottles", "code_info": "TE38139, Exp. 08/16, TE39022, Exp. 09/16,", "center_classification_date": "20140512", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "INDOMETHACIN Capsules USP, 50 mg, a) 100 count bottle, (NDC 0093-4030-01), b) 500 count bottle, (NDC 0093-4030-05), Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960", "report_date": "20140521", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D-1295-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67811", "termination_date": "20141114", "more_code_info": "", "recall_initiation_date": "20140324", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Amityville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67894", "recalling_firm": "Hi-Tech Pharmacal Co., Inc.", "address_1": "369 Bayview Ave", "address_2": "N/A", "postal_code": "11701-2801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0048-2015", "product_description": "HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg / 5mL, Net Wt 16 fl oz (473 mL), NDC 50383-796-16, Rx Only, Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, ALSO LABELED AS HydrOXYzine HCl Oral Solution, USP, 10 mg / 5 mL, Net Wt 16 fl oz (473 mL), NDC 10702-052-16, Rx Only, Manufactured for: KVK-TECH, INC. NEWTOWN, PA 18940, MADE IN USA, Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701.", "product_quantity": "451,916 bottles", "reason_for_recall": "Failed Impurity/Degradation Specification; out-of-specification result for one individual unknown impurity at the 24-month room temperature stability test station.", "recall_initiation_date": "20140401", "center_classification_date": "20141027", "termination_date": "20160921", "report_date": "20141105", "code_info": "Batch 609442 (exp. 4/2014), 609445 (exp. 4/2014), Batch 609919 (exp. 4/2014), Batch 609964 (exp. 5/2014), Batch 609966 (exp. 5/2014), Batch 610204 (exp. 5/2014), Batch 610406 (exp. 5/2014), Batch 610572 (exp. 6/2014), Batch 610575 (exp. 6/2014), Batch 610677 (exp. 6/2014), Batch 610808 (exp. 6/2014), Batch 611110 (exp. 7/2014), Batch 611201 (exp. 8/2014), Batch 611530 (exp. 8/2014), Batch 611645 (exp.9/2014), Batch 611891 (exp. 9/2014), Batch 611993 (exp. 10/2014), Batch 612328 (exp. 11/2014), Batch 612331 (exp. 11/2014), Batch No. 613050 (exp. 12/2014), Batch 613053 (exp. 12/2014), Batch 613172 (exp. 12/2014), Batch 613175 (exp. 12/2014), Batch 613738 (exp. 1/2015), Batch 613741 (exp. 1/2015), Batch 613744 (exp. 1/2015). Batch 613747 (exp. 1/2015), Batch 613852 (exp. 1/2015), Batch 613855 (exp. 2/2015), Batch 614448 (exp. 2/2015), Batch 614451 (exp. 3/2015), Batch 614914 (exp. 3/2015, Batch 614917 (exp. 3/2015), Batch 615331 (exp. 4/2015), Batch 615334 (exp. 4/2015), Batch 615797 (exp. 5/2015), Batch 615800 (exp. 5/2015), Batch 615947 (exp. 6/2015), Batch 615950 (exp. 6/2015), Batch 616356 (exp. 7/2015), Batch 616359 (exp. 7/2015), Batch 616362 (exp. 7/2015), Batch 616365 (exp. 7/2015), Batch 617066 (exp. 8/2015), Batch 617069 (exp. 8/2015), Batch 617432 (exp. 9/2015), Batch 617435 (exp. 9/2015), Batch 617951 (exp. 10/2015), Batch 617954 (exp. 11/2015), Batch 617957 (exp. 12/2015), Batch 617960 (exp. 12/2015), Batch 618918 (exp. 12/2015), Batch 618920 (exp. 12/2015), Batch 619173 (exp. 1/2016), Batch 619176 (exp. 1/2016), Batch 619543 (exp. 2/2016), Batch 619546 (exp. 2/2016), Batch 620099 (exp. 2/2016), Batch 620102 (exp. 2/2016), Batch 620338 (exp. 2/2016), and Batch 620341 (exp. 2/2016).", "more_code_info": ""}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Voriconazole 1% opthal", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1143-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: glyBURIDE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs:  sulfaSALAzine, Tablet, 500 mg, NDC 59762500001, Pedigree: AD46265_13, EXP: 5/15/2014;  ENTECAVIR, Tablet, 0.5 mg, NDC 00003161112, Pedigree: W003687, EXP: 6/26/2014;  RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: AD21790_22, EXP: 5/1/2014;  carBAMazepine ER, Tablet, 100 m", "address_2": "", "product_quantity": "500 Tablets", "code_info": "glyBURIDE, Tablet, 2.5 mg has the following codes:   Pedigree: AD46265_22, EXP: 5/15/2014;  Pedigree: W003688, EXP: 5/31/2014;  Pedigree: AD21790_55, EXP: 5/1/2014;  Pedigree: AD30140_34, EXP: 5/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "glyBURIDE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093834301.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-854-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ASPIRIN, CHEW Tablet, 81 mg may have potentially been mislabeled as one of the following drugs:  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD30028_4, EXP: 5/8/2014;  MODAFINIL, Tablet, 200 mg, NDC 00603466216, Pedigree: W002760, EXP: 6/6/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W003015, EXP: 6/12/2014;  VITAMIN B COMPLEX", "address_2": "", "product_quantity": "4246 CHEW Tablets", "code_info": "ASPIRIN, CHEW Tablet, 81 mg has the following codes:   Pedigree: AD33897_1, EXP: 5/9/2014;  Pedigree: W002773, EXP: 6/6/2014;  Pedigree: W003093, EXP: 6/13/2014;  Pedigree: W003459, EXP: 6/20/2014;  Pedigree: AD49582_1, EXP: 5/16/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN, CHEW Tablet, 81 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536329736.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-927-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Nashville", "address_1": "110 20th Ave N", "reason_for_recall": "Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.", "address_2": "", "product_quantity": "7 vials", "code_info": "Lot #: 41652, Expiry: 8/2/14;  Lot #: 41668, Expiry: 7/13/14", "center_classification_date": "20140425", "distribution_pattern": "MO, TN, MS, WI", "state": "TN", "product_description": "Phosphatidylcholine Solution for Injection, 50 mg/ mL, 50 mL Vial, Rx Only, Not for Resale.  John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.", "report_date": "20140507", "classification": "Class II", "openfda": {}, "recalling_firm": "John W Hollis Inc", "recall_number": "D-1257-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "67812", "termination_date": "20140501", "more_code_info": "", "recall_initiation_date": "20140317", "postal_code": "37203-2315", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ESTROPIPATE, Tablet, 0.75 mg may have potentially been mislabeled as the following drug:   MESALAMINE DR, Capsule, 400 mg, NDC 00430075327, Pedigree: AD34934_1, EXP: 1/31/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "ESTROPIPATE, Tablet, 0.75 mg has the following codes:   Pedigree: AD34934_4, EXP: 5/10/2014", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ESTROPIPATE, Tablet, 0.75 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591041401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-963-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "186 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 09242013@10, 07012013@12, 07092013@14, 08132013@22, 08282013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "Multitrace-4 pediatric injection ( zinc sulfate usp granular heptahydrate, cupric sulfate pentahydrate usp, manganese sulfate monohydrate usp, chromium chloride hexahydrate), Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-432-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MULTIVITAMIN/ MULTIMINERAL/ LUTEIN Capsule may be potentially mislabeled as    CAFFEINE, Tablet, 200 mg, NDC 24385060173, Pedigree: AD21846_37, EXP: 5/1/2014;  CAFFEINE, Tablet, 200 mg, NDC 24385060173, Pedigree: AD60240_42, EXP: 5/22/2014;  CAFFEINE, Tablet, 200 mg, NDC 24385060173, Pedigree: W003024, EXP: 6/12/2014;  MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD73", "address_2": "", "product_quantity": "204 Capsules", "code_info": "MULTIVITAMIN/ MULTIMINERAL/ LUTEIN Capsule has the following codes    Pedigree: AD21846_40, EXP: 5/2/2014;  Pedigree: AD60240_45, EXP: 5/22/2014;  Pedigree: W003025, EXP: 6/12/2014;  Pedigree: AD73521_37, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/ MULTIMINERAL/ LUTEIN Capsule, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 24208063210", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-535-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DESLORATADINE, Tablet, 5 mg may have potentially been mislabeled as the following drug:  ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD30180_28, EXP: 5/9/2014.", "address_2": "", "product_quantity": "101 Tablets", "code_info": "DESLORATADINE, Tablet, 5 mg has the following codes:   Pedigree: AD30993_5, EXP: 2/28/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DESLORATADINE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00085126401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-821-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: THYROID, Tablet, 30 mg may have potentially been mislabeled as one of the following drugs:  OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg, NDC 11523726503, Pedigree: AD70655_20, EXP: 5/29/2014;  NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 37205098769, Pedigree: AD73623_7, EXP: 5/30/2014;  PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W002697, EXP: 6/5/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "THYROID, Tablet, 30 mg has the following codes:   Pedigree: AD65323_1, EXP: 5/29/2014;  Pedigree: AD73611_1, EXP: 5/30/2014;  Pedigree: W002847, EXP: 6/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "THYROID, Tablet, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456045801.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-913-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LOVASTATIN, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs:  ASPIRIN EC DR, Tablet, 81 mg, NDC 49348098015, Pedigree: AD28349_1, EXP: 2/28/2014;  FLUVASTATIN SODIUM, Capsule, 20 mg, NDC 00078017615, Pedigree: AD73597_7, EXP: 5/31/2014;  DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071204, Pedigree: W003247, EXP: 6/17/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "LOVASTATIN, Tablet, 20 mg has the following codes:  Pedigree: AD28369_1, EXP: 5/7/2014;  Pedigree: AD73597_10, EXP: 5/31/2014;  Pedigree: W003263, EXP: 6/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LOVASTATIN, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185007201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-879-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0077-2015", "product_description": "Dexamethasone sodium phosphate 24 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "30 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08122014@14, Exp 2/8/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["NDA020936"], "brand_name": ["PAROXETINE HYDROCHLORIDE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp"], "product_ndc": ["60505-1316", "60505-1317", "60505-1318", "60505-3673", "60505-3674", "60505-3675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE"], "rxcui": ["1738803", "1738805", "1738807"], "spl_id": ["f641c7b3-f7d2-9446-e589-074ac368853a"], "spl_set_id": ["087ff0d3-1761-47ea-a8c1-7c4cb679af97"], "package_ndc": ["60505-1316-3", "60505-1317-3", "60505-1318-3", "60505-3673-3", "60505-3674-3", "60505-3675-3"], "is_original_packager": [true], "upc": ["0360505367436", "0360505367535", "0360505367337"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "68967", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1574-2014", "product_description": "Paroxetine HCL Controlled-Release Tablets 12.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3673-3", "product_quantity": "", "reason_for_recall": "Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.", "recall_initiation_date": "20140324", "center_classification_date": "20140903", "termination_date": "20140923", "report_date": "20140910", "code_info": "Lot # 2A001, Exp. 01/15  Lot # 2A002, Exp. 01/15  Lot # 2C003, Exp. 03/15  Lot # 2F005, Exp. 06/15  Lot # 2G006, Exp. 07/15", "more_code_info": ""}, {"country": "United States", "city": "Oklahoma City", "address_1": "755 Research Pkwy Ste 150", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.", "address_2": "", "product_quantity": "", "code_info": "all lot codes 30 ml and 50 ml", "center_classification_date": "20140729", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Therametics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Complexion Repair Acne Treatment System Kit and the Complexion Repair Acne Travel Kit with SKU numbers of CR1005 and CR1007, respectively.", "report_date": "20140806", "classification": "Class II", "openfda": {}, "recalling_firm": "Dermamedics, L.L.C.", "recall_number": "D-1495-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67247", "termination_date": "20170314", "more_code_info": "", "recall_initiation_date": "20140110", "postal_code": "73104-3621", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mission Viejo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66889", "recalling_firm": "Tower Pharmacy and Compounding", "address_1": "26732 Crown Valley Parkway", "address_2": "N/A", "postal_code": "92691", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA", "recall_number": "D-384-2014", "product_description": "Phenylephrine Nasal  1% Spray, 480 mL bottles, For Office Use, Tower Pharmacy, 26732 Crown Valley Pkwy, Suite 101, Mission Viejo, CA 92691", "product_quantity": "2 Bottles", "reason_for_recall": "Microbial Contamination of Non Sterile Products: Tower Pharmacy is recalling the Phenylephrine Nasal Spray 1% because of possible microbial contamination.", "recall_initiation_date": "20131116", "center_classification_date": "20131220", "termination_date": "20140113", "report_date": "20140101", "code_info": "Lot  # 13603, Exp 12/13", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units may be potentially mislabeled as one of the following drugs:  ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003726, EXP: 6/26/2014;  LANTHANUM CARBONATE, CHEW Tablet, 500 mg, NDC 54092025290, Pedigree: W002790, EXP: 6/6/2014;  CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: W002844, EXP: 6/7/2014;  AT", "address_2": "", "product_quantity": "400 Capsules", "code_info": "PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units has the following codes:   Pedigree: W003731, EXP: 6/26/2014;  Pedigree: W002819, EXP: 6/7/2014;  Pedigree: W002849; EXP: 6/7/2014;  Pedigree: AD30180_4, EXP: 5/8/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, Rx only, Distributed by: AidaPak Service, LLC,  NDC 00032121201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-783-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Chester", "address_1": "12230 Iron Bridge Rd", "reason_for_recall": "Crystallization; visible crystals from the active ingredient formed due to extreme cold temperatures during shipping", "address_2": "Ste. C", "product_quantity": "250 syringes", "code_info": "Lot number: 12052013:03  Expiration date: 06/03/2014", "center_classification_date": "20140317", "distribution_pattern": "Product was distributed in Virginia and Maryland.", "state": "VA", "product_description": "Hydroxyprogesterone Caproate 250mg/ml in Sesame Oil, 1 ml injectable solution, in 3 ml single dose syringes; a multi-ingredient compounded medication in bulk, containing Benzoyl Benzoate USP 0.46 ml/1ml, and Benzyl Alcohol 0.02 ml/1ml; syringe is labeled in part ***FOR INJECTION USE ONLY***RX South LLC DBA RX3 12230 Iron Bridge Rd Chester, VA 23831***", "report_date": "20140326", "classification": "Class II", "openfda": {}, "recalling_firm": "RX South LLC DBA RX3 Pharmacy", "recall_number": "D-1164-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67432", "termination_date": "20140410", "more_code_info": "", "recall_initiation_date": "20140128", "postal_code": "23831-1534", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; PROMETHAZINE HCL, Tablet, 25 mg may be potentially mislabeled as    CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002574, EXP: 6/3/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "PROMETHAZINE HCL, Tablet, 25 mg has the following code    Pedigree: W002578, EXP: 6/3/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PROMETHAZINE HCL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 65162052110", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-707-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68158", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1316-2014", "product_description": "Laroscorbine Platinium (vitamin C/collagen) injectable I.V. solution, 1 gm/0.35 gm, 5 mL ampoules, packaged in 10-count ampoules per box, Laboratories Roche Nicholas S.A., F-74240 Gaillard, - Tel.: 04 50 87 70 70, Fabricant : Produits Roche, 52, Bld du Parc, 92521 Neulilly -sur-Seine Cedex, barcode *3421357*", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.", "recall_initiation_date": "20140429", "center_classification_date": "20140513", "report_date": "20140521", "code_info": "Lot #: F040, Exp 08/16", "more_code_info": ""}, {"status": "Terminated", "city": "Suffern", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA010187"], "brand_name": ["RITALIN"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0439", "0078-0440", "0078-0441"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091150", "1091379", "1091392", "1091395", "1091497", "1091500"], "spl_id": ["00db4d6e-410b-43a1-ab5e-7047f525e68d"], "spl_set_id": ["c0bf0835-6a2f-4067-a158-8b86c4b0668a"], "package_ndc": ["0078-0439-05", "0078-0440-05", "0078-0441-05"], "is_original_packager": [true], "upc": ["0300780441056", "0300780439053"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "67633", "recalling_firm": "Novartis Pharmaceuticals Corp.", "address_1": "25 Old Mill Rd", "address_2": "N/A", "postal_code": "10901-4106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1228-2014", "product_description": "Ritalin HCl (methylphenidate HCl) USP, 20 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901  Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0441-05", "product_quantity": "10,781 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets.  Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert.  The individual Medication Guides are attached to the Package Insert via a perforation.  Although t", "recall_initiation_date": "20140303", "center_classification_date": "20140408", "termination_date": "20141202", "report_date": "20140416", "code_info": "Lot #: F0131"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Cyanocobalamin 100mcg/ml injection", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1103-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx 29184 Exp 5/28/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Levofloxacin 750 mg/250 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx #29184, Discard After 05/28/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1453-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CHLORTHALIDONE, Tablet, 50 mg may have potentially been mislabeled as the following drug:  SENNOSIDES, Tablet, 8.6 mg, NDC 00182109301, Pedigree: W002979, EXP: 6/11/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "CHLORTHALIDONE, Tablet, 50 mg has the following codes:   Pedigree: W002988, EXP: 6/11/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CHLORTHALIDONE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378021301.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-889-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Suite 200", "reason_for_recall": "Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it  because fliptop vial crimps were loose or missing.", "address_2": "", "product_quantity": "220 syringes", "code_info": "Lots 7083-0, 7202-0, 7222-0 Exp. 08/14", "center_classification_date": "20140821", "distribution_pattern": "Texas and Georgia", "state": "TX", "product_description": "fentaNYL 2750 mcg/55 mL (50 mcg/mL) in prefilled syringe, COMPOUNDED DRUG,   For Institutional or Office Use Only--Not for Resale   Federal Law Prohibits Dispensing without Prescription  Healix Infusion Therapy, Inc.  (866) 298-4826 1075 West Park One Drive, Suite 200, Sugar Land, Texas, 77478  NDC  75901-8008-33", "report_date": "20140827", "classification": "Class II", "openfda": {}, "recalling_firm": "Healix Infusion Therapy, Inc.", "recall_number": "D-1554-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69056", "termination_date": "20150825", "more_code_info": "", "recall_initiation_date": "20140627", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0109-2015", "product_description": "Paraben water for injection packaged in a sterile 1000 mL clear bottle, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "3 bottles", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03102014@23, Exp 9/6/2014; 05282014@16, Exp 11/24/2014; 08132014@18, Exp 2/9/2015", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PIOGLITAZONE HCL, Tablet, 15 mg may have potentially been mislabeled as one of the following drugs:  DOXYCYCLINE MONOHYDRATE, Capsule, 100 mg, NDC 49884072703, Pedigree: AD52778_25, EXP: 5/20/2014;  LOVASTATIN, Tablet, 20 mg, NDC 00185007201, Pedigree: W003263, EXP: 6/17/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "PIOGLITAZONE HCL, Tablet, 15 mg has the following codes:   Pedigree: AD52778_70, EXP: 5/21/2014;  Pedigree: W003264, EXP: 6/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PIOGLITAZONE HCL, Tablet, 15 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093204856.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-835-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg) may be potentially mislabled as one of the following drugs:  CYCLOBENZAPRINE HCL, Tablet, 5 mg, NDC 00591325601, Pedigree: AD73525_7, EXP: 5/30/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD21846_11, EXP: 5/1/2014.", "address_2": "", "product_quantity": "400 Tablets", "code_info": "LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg) has the following codes:  Pedigree: AD73525_16, EXP: 5/30/2014;  Pedigree: AD21790_25, EXP: 5/1/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002025.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-789-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1522-2014", "product_description": "Vitamin B12 Cyanocobalamin Injection USP 1000 mcg/ml, Sterile, 10 ml vial and 30 ml vial, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0148-2015", "product_description": "Tri-mix, 30 mg/0.5 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "5 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08132014@36, Exp 11/11/2014", "more_code_info": ""}, {"country": "United States", "city": "Temple", "address_1": "5920 S General Bruce Dr", "reason_for_recall": "Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense.", "address_2": "Ste 100", "product_quantity": "3,529 Vials", "code_info": "Lot #: 86513, Exp 07/23/2014", "center_classification_date": "20141009", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133", "report_date": "20141015", "classification": "Class I", "openfda": {}, "recalling_firm": "Unique Pharmaceutical, Ltd", "recall_number": "D-0011-2015", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68841", "termination_date": "20160224", "more_code_info": "", "recall_initiation_date": "20140718", "postal_code": "76502-5803", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Cyano B-12 p-f 1000mcg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1104-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; FOSINOPRIL SODIUM Tablet, 10 mg may be potentially mislabeled as    CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: AD46414_10, EXP: 5/16/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "FOSINOPRIL SODIUM, Tablet, 10 mg has the following code    Pedigree: AD46414_19, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FOSINOPRIL SODIUM Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505251002", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-657-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66839", "recalling_firm": "Vitality Research Labs LLC", "address_1": "8840 W Russell Rd #245", "address_2": "N/A", "postal_code": "89148", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1364-2014", "product_description": "vitaliKOR Ready When You Are, Fast Acting Formula Dietary Supplement capsules, 40 count bottle, Distributed by Vitality Research Labs, LLC, Las Vegas, NV 89148.", "product_quantity": "11,523 bottles of lot K58Q; 54,255 bottles of lot F50Q", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling found undeclared  vardenafil and tadalafil in vitaliKOR capsules", "recall_initiation_date": "20131119", "center_classification_date": "20140611", "termination_date": "20140612", "report_date": "20140618", "code_info": "LOT K58Q  Exp 01/16  LOT F50Q  Exp 07/16"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076242"], "brand_name": ["CALCITRIOL"], "generic_name": ["CALCITRIOL"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0054-3120"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CALCITRIOL"], "rxcui": ["313932"], "spl_id": ["2b8745f3-5289-474e-bd44-48b59a40dd78"], "spl_set_id": ["3289b482-8733-484d-b1db-d7f4cdcd1ac2"], "package_ndc": ["0054-3120-41"], "is_original_packager": [true], "nui": ["M0004229", "N0000175908"], "pharm_class_cs": ["Cholecalciferol [CS]"], "pharm_class_epc": ["Vitamin D3 Analog [EPC]"], "unii": ["FXC9231JVH"]}, "product_type": "Drugs", "event_id": "68389", "recalling_firm": "Boehringer Ingelheim Roxane Inc", "address_1": "1809 Wilson Rd", "address_2": "", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide", "recall_number": "D-1427-2014", "product_description": "Calcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-3120-41.", "product_quantity": "5364 bottles", "reason_for_recall": "Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time point", "recall_initiation_date": "20140501", "center_classification_date": "20140709", "termination_date": "20150401", "report_date": "20140716", "code_info": "Lot # 360122A, EXP Date: MAY 2015", "more_code_info": ""}, {"status": "Terminated", "city": "Attleboro", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68136", "recalling_firm": "Mangiacotti", "address_1": "117 Pleasant Street", "address_2": "N/A", "postal_code": "02703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1305-2014", "product_description": "Mangiacotti\t - Ocean Hand Sanitizer Spray, alcohol free, 0.5 fl Oz. 15 mL spray bottle, UPC 870678005320, Active Ingredient Benzalkonium Chloride 0.1%, Dist By: Mangiacotti,  Attleboro, MA 02703.", "product_quantity": "N/A", "reason_for_recall": "Microbial Contamination of Non-Sterile Products:  Elevated counts of bacteria was found, Serratia liquefaciens.", "recall_initiation_date": "20131227", "center_classification_date": "20140506", "termination_date": "20160429", "report_date": "20140514", "code_info": "Lot Code:  13350"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018609"], "brand_name": ["HEPARIN SODIUM IN SODIUM CHLORIDE"], "generic_name": ["HEPARIN SODIUM"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0424", "0338-0431", "0338-0433", "0338-0428"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HEPARIN SODIUM"], "rxcui": ["1658690", "1658692"], "spl_id": ["68b37381-6db4-4ac0-ba6b-3204add02665"], "spl_set_id": ["0d929726-76c3-48fc-b4e7-fd06409f9fb3"], "package_ndc": ["0338-0431-03", "0338-0433-04", "0338-0424-18", "0338-0428-12"], "is_original_packager": [true], "unii": ["ZZ45AB24CA"]}, "product_type": "Drugs", "event_id": "69634", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0276-2015", "product_description": "Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only, Manufactured for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015 by Baxter Healthcare Corporation 250 Road 144 Jayuya, Puerto Rico, 00664, NDC 0338-0431-03", "product_quantity": "127,746 Viaflex Plus Container", "reason_for_recall": "Subpotent Drug: Heparin raw material was found to have low potency", "recall_initiation_date": "20141030", "center_classification_date": "20141124", "termination_date": "20160922", "report_date": "20141203", "code_info": "Lot #: N003061; N003079; and N003087, Exp 2/29/2016", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx # 29114, Exp 05/13/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Cubicin 444 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29114, Discard After 05/13/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1467-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DILTIAZEM HCL, Tablet, 120 mg, may have potentially been mislabeled as the following drug:  NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001, Pedigree: AD329737, EXP: 5/9/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "DILTIAZEM HCL, Tablet, 120 mg, has the following codes:   Pedigree: AD30197_1, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DILTIAZEM HCL, Tablet, 120 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093032101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-824-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68348", "recalling_firm": "Bausch & Lomb, Inc.", "address_1": "8500 Hidden River Pkwy", "address_2": "N/A", "postal_code": "33637-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Canada, and Hong Kong.", "recall_number": "D-1411-2014", "product_description": "Sodium Chloride Hypertonicity Ophthalmic Ointment, 5%, 1/8 oz. (3.5 g) tube per carton, Distributed by Major Pharmaceuticals, 31778 Enterprise Drive, Livonia, MI  48150, NDC 0904-5315-38, UPC 3 09045 31538 5.", "product_quantity": "35,253 tubes", "reason_for_recall": "Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.", "recall_initiation_date": "20140410", "center_classification_date": "20140625", "termination_date": "20170414", "report_date": "20140702", "code_info": "Lot #'s: 159101, Exp 02/15; 169271, Exp 09/15; and 170481, Exp 10/15"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Sodium Bicarbonate 8.4% inj.", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1131-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Bank Demerara", "state": "", "country": "Guyana", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69206", "recalling_firm": "New Gpc Inc.", "address_1": "Lot A1, Farm", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D0032-2015", "product_description": "Ferrol EXPECTORANT, Net Contents: 100 mL.  Product packaged within a plastic bottle individually placed in small blue carton.  Manufactured by: NEW GPC INC. A1 Farm, EBD.  Country of Origin Guyana.", "product_quantity": "36 units", "reason_for_recall": "Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A..", "recall_initiation_date": "20140807", "center_classification_date": "20141017", "termination_date": "20180604", "report_date": "20141029", "code_info": "Batch Numbers: 305206", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0055-2015", "product_description": "Acetylcysteine 20% (PF) inhalant solution packaged in either a 3 mL or 7 mL vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "450 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07022014@43, Exp 9/30/2014; 08052014@1, Exp 11/3/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Bethlehem", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077867"], "brand_name": ["SEVOFLURANE"], "generic_name": ["SEVOFLURANE"], "manufacturer_name": ["Piramal Critical Care Inc"], "product_ndc": ["66794-015"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["SEVOFLURANE"], "spl_id": ["404235ad-60f3-7e4a-e063-6394a90a47d9"], "spl_set_id": ["3dbab949-6ab7-4040-9c81-314e5bb61d41"], "package_ndc": ["66794-015-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["38LVP0K73A"]}, "product_type": "Drugs", "event_id": "68004", "recalling_firm": "Piramal Critical Care, Inc.", "address_1": "3950 Schelden Cir", "address_2": "", "postal_code": "18017-8936", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "To wholesale distributors and retailers located Nationwide.", "recall_number": "D-1262-2014", "product_description": "Sevoflurane, USP (Inhalation Anesthetic), Rx Only, 250 mL Amber Bottle. Manufactured By: Piramal Critical Care, 3950 Schelden Circle, Bethlehem, PA 18017.  NDC: 66794-015-25.", "product_quantity": "12,600 bottles", "reason_for_recall": "Failed pH Specifications: product was too acidic.", "recall_initiation_date": "20140407", "center_classification_date": "20140425", "termination_date": "20141215", "report_date": "20140507", "code_info": "Lot #: S2611I28 (exp 9/16), S2511I14 (exp 9/16), S2531I16 (exp 9/16), S2721J21 (exp 10/16),  S2871K03 (exp 11/16), S2881K03 (exp 11/16), and S2931K07 (exp 11/16).", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; BISOPROLOL FUMARATE Tablet, 5 mg may be potentially mislabeled as:    ESTROPIPATE, Tablet, 0.75 mg, NDC 00591041401, Pedigree: AD34934_4, EXP: 5/10/2014.", "address_2": "", "product_quantity": "299 Tablets", "code_info": "BISOPROLOL FUMARATE Tablet, 5 mg has the following code    Pedigree: AD34934_7, EXP: 5/10/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BISOPROLOL FUMARATE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 29300012601", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-542-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA016964"], "brand_name": ["MARCAINE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-0525", "0409-1559", "0409-1560", "0409-1582", "0409-1587", "0409-1610", "0409-1746", "0409-1749", "0409-1752", "0409-1755", "0409-2510", "0409-7535", "0409-1250", "0409-5010", "0409-1530", "0409-7510", "0409-2253"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012381", "1012384", "1012388", "1012396", "1012400", "1012404", "1012406", "1672917", "1672919", "1673242", "1673243", "1724786", "1724787", "1724794", "1724796", "1724880", "1724884", "1725044", "1725046", "1725078", "1725079", "1725082", "1725083", "1867594", "1867596", "1867612", "1867614"], "spl_id": ["b00b78c3-c70d-49b9-a381-6a1496f74153"], "spl_set_id": ["67578b56-7540-487e-1fba-481255620e78"], "package_ndc": ["0409-1559-18", "0409-1559-10", "0409-1559-19", "0409-1559-30", "0409-1560-18", "0409-1560-10", "0409-1560-19", "0409-1560-29", "0409-1582-18", "0409-1582-10", "0409-1582-19", "0409-1582-29", "0409-1587-50", "0409-1610-50", "0409-1746-70", "0409-1746-10", "0409-1746-71", "0409-1746-30", "0409-1749-70", "0409-1749-10", "0409-1749-71", "0409-1749-29", "0409-1752-50", "0409-1755-50", "0409-2510-01", "0409-2510-25", "0409-7535-01", "0409-7535-25", "0409-1250-01", "0409-1250-25", "0409-5010-01", "0409-5010-25", "0409-1530-01", "0409-1530-25", "0409-0525-01", "0409-0525-25", "0409-7510-01", "0409-7510-25", "0409-2253-01", "0409-2253-25"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "66503", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1161-2014", "product_description": "Marcaine (bupivacaine HCl) injection, USP, 0.25%, 30 mL single-dose vials-preservative free, packaged in 10-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL  60045, NDC 0409-1559-30.", "product_quantity": "40,360 vials", "reason_for_recall": "Presence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored.", "recall_initiation_date": "20131018", "center_classification_date": "20140314", "termination_date": "20151218", "report_date": "20140326", "code_info": "Lot 25-220-DD, Exp 1JAN2015", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: guanFACINE HCl, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs:  buPROPion HCl ER, Tablet, 200 mg, NDC 47335073886, Pedigree: W002727, EXP: 6/6/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD39588_7, EXP: 5/13/2014;  OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg, NDC 11523726503, Pedigree: W003873, EXP: 6/2", "address_2": "", "product_quantity": "500 Tablets", "code_info": "guanFACINE HCl, Tablet, 1 mg has the following codes:   Pedigree: W002728, EXP: 4/30/2014;  Pedigree: AD39611_1, EXP: 4/30/2014;  Pedigree: W003791, EXP: 6/27/2014;  Pedigree: AD73525_13, EXP: 4/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "guanFACINE HCl, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591044401.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-965-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Greensboro", "address_1": "8009 Industrial Village Rd", "reason_for_recall": "Correct Labeled Product Mispacked; correct labeled bottles of Assured Ibuprofen softgels were packaged into cartons of Assured Naproxen Sodium Tablets, USP", "address_2": "", "product_quantity": "11,640 boxes", "code_info": "Lot FH4102A UPC #639277223685, Exp. Date 3/16", "center_classification_date": "20141113", "distribution_pattern": "Nationwide", "state": "NC", "product_description": "Assured Naproxen Sodium Tablets, USP 220 mg., 15 count bottle, Repackaged by Contract Packaging Resources, Inc 8009 Industrial Village Road Greensboro, NC 27409 Distributed by  Greenbrier International, Inc Chesapeake, VA 23320", "report_date": "20141119", "classification": "Class II", "openfda": {}, "recalling_firm": "Contract Packaging Resources Inc.", "recall_number": "D-0248-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "69554", "termination_date": "20160105", "more_code_info": "", "recall_initiation_date": "20141010", "postal_code": "27409-9604", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0123-2015", "product_description": "Polyhexamethylene biguanide 2% stock solution packaged in an opaque squeeze bottle eye dropper, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "10 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08112014@24, Exp 11/9/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg) may have potentially been mislabeled as one of the following drugs:  CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD30180_1, EXP: 5/8/2014;  carBAMazepine ER, Capsule, 200 mg, NDC 66993040832, Pedigree: AD32764_14, EXP: 5/14/2014;  CHLORTHALIDONE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 00378022201, Pedigree:", "address_2": "", "product_quantity": "600 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg) has the following codes:   Pedigree: AD30140_40, EXP: 5/7/2014;  Pedigree: AD46265_40, EXP: 5/15/2014;  Pedigree: AD73525_49, EXP: 5/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00527134101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-920-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bannockburn", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020451"], "brand_name": ["PHOTOFRIN"], "generic_name": ["PORFIMER SODIUM"], "manufacturer_name": ["Pinnacle Biologics, Inc."], "product_ndc": ["76128-155"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PORFIMER SODIUM"], "rxcui": ["242166", "687066"], "spl_id": ["3f74d94c-ce73-4f3f-abc6-050a8d86dac4"], "spl_set_id": ["5c4841b4-fbc0-4163-8ee1-cb28629cbfbf"], "package_ndc": ["76128-155-75"], "is_original_packager": [true], "upc": ["0376128155756"], "unii": ["Y3834SIK5F"]}, "product_type": "Drugs", "event_id": "67688", "recalling_firm": "Pinnacle Biologics Inc", "address_1": "2801 Lakeside Dr Ste 209", "address_2": "N/A", "postal_code": "60015-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide and Taiwan", "recall_number": "D-1157-2014", "product_description": "Photofrin (porfimer sodium) for Injection, 75 mg Single Use Flip-Top Vial, Rx Only. Manufactured for: Pinnacle Biologics, Inc. Bannockburn, IL 60015. NDC:76128-155-75", "product_quantity": "261 vials", "reason_for_recall": "Stability Data Does Not Support Expiry: Printed expiration date should be Nov 2013 rather than Nov 2014.", "recall_initiation_date": "20140210", "center_classification_date": "20140312", "termination_date": "20150522", "report_date": "20140319", "code_info": "Lot Number: 0M396; Expiry: Nov 2014"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; OLANZapine, Tablet, 7.5 mg may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 175 mcg, NDC 00527135001, Pedigree: AD46265_37, EXP: 5/15/2014;  LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: AD60272_73, EXP: 5/22/2014;  MIRTAZAPINE, Tablet, 7.5 mg, NDC 59762141503, Pedigree: AD73525_55, EXP: 5/30/2014.", "address_2": "", "product_quantity": "210 Tablets", "code_info": "OLANZapine, Tablet, 7.5 mg has the following codes    Pedigree: AD46265_46, EXP: 5/15/2014;  Pedigree: AD60272_79, EXP: 5/22/2014;  Pedigree: AD73525_58, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OLANZapine Tablet, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 55111016530", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-619-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "New York", "address_1": "767 5th Ave Fl 47th", "reason_for_recall": "Stability Data Does Not Support Expiry", "address_2": "", "product_quantity": "3,791 tubes", "code_info": "All lot codes and shipment dates are being recalled. 2.6oz/75ml. in a light green carton, UPC: 8-82381-07901-7 Code: D079-01-1000", "center_classification_date": "20140724", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "DENBLAN Anticavity Fluoride Toothpaste, Whitening formula, sodium monofluorophosphate 0.76%, 2.6 oz/75 mL tube, Laboratories Darphin, Dist, Paris France", "report_date": "20140730", "classification": "Class III", "openfda": {}, "recalling_firm": "Estee Lauder Inc", "recall_number": "D-1452-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "68449", "termination_date": "20151119", "more_code_info": "", "recall_initiation_date": "20140606", "postal_code": "10153-0023", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PSEUDOEPHEDRINE HCL, Tablet, 30 mg may be potentially mislabeled as     D-ALPHA TOCOPHERYL ACETATE, Capsule, 400 units, NDC 49348041010, Pedigree: AD52993_28, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "PSEUDOEPHEDRINE HCL, Tablet, 30 mg has the following code    Pedigree: AD52993_37, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PSEUDOEPHEDRINE HCL, Tablet, 30 mg, Rx in Oregon, Distributed by: AidaPak Service, LLC, NDC 00904505360", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-469-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA085692"], "brand_name": ["TRIAMCINOLONE ACETONIDE"], "generic_name": ["TRIAMCINOLONE ACETONIDE"], "manufacturer_name": ["E. Fougera & Co. a division of Fougera Pharmaceuticals Inc."], "product_ndc": ["0168-0002", "0168-0003", "0168-0004"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TRIAMCINOLONE ACETONIDE"], "rxcui": ["1014314", "1085644", "1085686"], "spl_id": ["719f34d8-deb8-446f-a201-3f74fed4e831"], "spl_set_id": ["92a1ded0-8e1a-4994-9c8a-89e84fc85c94"], "package_ndc": ["0168-0003-15", "0168-0003-80", "0168-0004-15", "0168-0004-80", "0168-0004-16", "0168-0002-15"], "is_original_packager": [true], "upc": ["0301680003153", "0301680002156", "0301680004150", "301680004808"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["F446C597KA"]}, "product_type": "Drugs", "event_id": "67329", "recalling_firm": "Fougera Pharmaceuticals  Inc.", "address_1": "60 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3838", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1152-2014", "product_description": "Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York  11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.", "product_quantity": "493,192 tubes", "reason_for_recall": "Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.", "recall_initiation_date": "20140129", "center_classification_date": "20140307", "termination_date": "20151208", "report_date": "20140319", "code_info": "Lot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx 29162 Exp. 5/21/2014", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Nafcillin 12 gm/300 mL, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29162, Discard After 05/21/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1462-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68130", "recalling_firm": "Prestige Brands Holdings", "address_1": "660 White Plains Rd", "address_2": "", "postal_code": "10591-5139", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, and one consignee in Libya", "recall_number": "D-1353-2014", "product_description": "PediaCare brand DAY & NIGHT Value Pack DAYTIME MULTI-SYMPTOM Cold (dextromethorphan HBr 5 mg and Phenylephrine HCl 2.5 mg) and NIGHTTIME MULTI-SYMPTOM Cold (diphenhydramine HCl 6.25 mg and phenylephrine HCl 2.5 mg), 4 FL oz (118 mL) bottles, one each of DAYTIME MULTI-SYMPTOM Cold, Distributed by Medtech Products, Inc., Tarrytown, NY --- UPC 814832013523", "product_quantity": "17,479 cases/12 dual packs", "reason_for_recall": "Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution", "recall_initiation_date": "20140425", "center_classification_date": "20140528", "termination_date": "20150915", "report_date": "20140604", "code_info": "UPC 814832013523    Lots: Expiry Date  148342 07/2015  148347 08/2015  149297 08/2015  149382 07/2015  149516 08/2015  152298 08/2015  73143 04/2014  73719 05/2014  74195 06/2014  74805 06/2014  75180 06/2014  79186 09/2014  79323 09/2014", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may have potentially been mislabeled as the following drug:  PRAMIPEXOLE DI-HCL, Tablet, 0.25 mg, NDC 16714058501, Pedigree: W003761, EXP: 6/26/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "MYCOPHENOLATE MOFETIL, Capsule, 250 mg has the following codes:   Pedigree: W003763, EXP: 6/26/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378225001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-904-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Cyano B-12 (Cmpd) 1000mcg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1105-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; prednisoLONE, Tablet, 5 mg may be potentially mislabeled as    ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, NDC 00597000160, Pedigree: W003644, EXP: 8/24/2013.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "prednisoLONE, Tablet, 5 mg has the following code    Pedigree: W003627, EXP: 6/25/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "prednisoLONE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC,NDC 16477050501", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-513-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040361"], "brand_name": ["DEXTROAMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0952", "0555-0953"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROAMPHETAMINE SULFATE"], "rxcui": ["884385", "884386"], "spl_id": ["e339af0f-084a-4d19-8013-3ccb826816d0"], "spl_set_id": ["ec2d13f3-d14f-47e4-abe9-7763f95a8e94"], "package_ndc": ["0555-0952-02", "0555-0953-02"], "is_original_packager": [true], "unii": ["JJ768O327N"]}, "product_type": "Drugs", "event_id": "68225", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1408-2014", "product_description": "Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.", "product_quantity": "9,882 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.", "recall_initiation_date": "20140501", "center_classification_date": "20140623", "termination_date": "20141209", "report_date": "20140702", "code_info": "Lot # 34013122A, Exp 11/15"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075591"], "brand_name": ["FAMOTIDINE"], "generic_name": ["FAMOTIDINE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-5197"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["FAMOTIDINE"], "rxcui": ["199739"], "spl_id": ["19d9e59f-3373-4237-b252-d3d6ba9e58cd"], "spl_set_id": ["97c33213-f415-4718-8466-9aa50371af70"], "package_ndc": ["0338-5197-41"], "is_original_packager": [true], "nui": ["N0000000151", "N0000175784"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "unii": ["5QZO15J2Z8"]}, "product_type": "Drugs", "event_id": "68171", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0293-2015", "product_description": "Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic,  Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.", "product_quantity": "19,152 Containers", "reason_for_recall": "Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.", "recall_initiation_date": "20140424", "center_classification_date": "20141210", "termination_date": "20150616", "report_date": "20141217", "code_info": "Lot #: NC082768, Exp 12/23/2014"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69445", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0053-2015", "product_description": "APLENZIN\u00bf (bupropion hydrobromide), extended-release tablets, 522 mg, a) 7-count HDPE bottle (NDC 0024-5812-07), b) 30-count HDPE bottle (NDC 0024-5812-30), Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7", "product_quantity": "55,650 HDPE bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert", "recall_initiation_date": "20140605", "center_classification_date": "20141028", "termination_date": "20170727", "report_date": "20141105", "code_info": "Lot #:  a) 13E023P; Exp. 03/16    Lot #:  b)   12J063P;  Exp. 07/15   12K063P; Exp. 09/15   12K060P; Exp. 07/15  12M073P; Exp. 09/15   13A036P; Exp. 11/15   13B035P; Exp. 11/15  13C046P; Exp. 11/15   13D060P; Exp. 11/15   13E030P; Exp. 03/16  13E031P; Exp. 03/16  13F003P; Exp. 03/16  13K034P; Exp. 03/16  14A001P; Exp. 10/16", "more_code_info": ""}, {"status": "Terminated", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022525"], "brand_name": ["NAMENDA"], "generic_name": ["MEMANTINE HYDROCHLORIDE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0456-3428", "0456-3407", "0456-3414", "0456-3421", "0456-3400"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MEMANTINE HYDROCHLORIDE"], "rxcui": ["996594", "996597", "996603", "996605", "996609", "996611", "996615", "996617", "996624", "996633"], "spl_id": ["59743420-cc2e-4578-9420-513694a3972d"], "spl_set_id": ["710f523f-0158-4639-8ce7-57598247d48c"], "package_ndc": ["0456-3407-33", "0456-3414-33", "0456-3414-90", "0456-3414-11", "0456-3414-63", "0456-3421-33", "0456-3428-33", "0456-3428-90", "0456-3428-11", "0456-3428-63", "0456-3400-29"], "is_original_packager": [true], "unii": ["JY0WD0UA60"]}, "product_type": "Drugs", "event_id": "66838", "recalling_firm": "Forest Pharmaceuticals Inc", "address_1": "13600 Shoreline Dr", "address_2": "", "postal_code": "63045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1064-2014", "product_description": "Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only,  Forest Pharmaceuticals Inc., St. Louis, MO 63045  NDC 0456-3400-29.", "product_quantity": "3,950 packs", "reason_for_recall": "Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.", "recall_initiation_date": "20131113", "center_classification_date": "20140204", "termination_date": "20140507", "report_date": "20140212", "code_info": "Lot  1113661 Exp. 01/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; BISACODYL EC, Tablet, 5 mg may be potentially mislabeled as    CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD37056_13, EXP: 5/10/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "BISACODYL EC, Tablet, 5 mg has the following code    Pedigree: AD34931_1, EXP: 5/9/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BISACODYL EC, Tablet, 5 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904792760", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-493-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units may be potentially mislabeled as the following drug:  ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, NDC 00597000160, Pedigree: AD70639_4, EXP: 7/28/2013.", "address_2": "", "product_quantity": "12 months", "code_info": "PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units has the following codes:   Pedigree: AD70639_7, EXP: 5/29/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, Rx only, Distributed by: AidaPak Service, LLC,  NDC 00032121207.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-784-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0145-2015", "product_description": "Trimethoprim/sulfadiazine excipient stock solution injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "100 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06252014@23, Exp 12/22/2014", "more_code_info": ""}, {"country": "United States", "city": "Duluth", "address_1": "3802 Satellite Blvd", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Product contains an undeclared drug, sibutramine, making it an unapproved new drug.", "address_2": "Suite 101", "product_quantity": "593 bottles", "code_info": "All lots (lot 109400, Exp 12/31/2016)", "center_classification_date": "20140312", "distribution_pattern": "Nationwide and  Australia, Canada.", "state": "GA", "product_description": "BEST Slim, Dietary Supplement, 100% Natural Weight Loss Pill, 40 Pills per bottle, Distributed by CTV Best Group Inc., P.O. Box 956452, Duluth, GA 30095.", "report_date": "20140319", "classification": "Class I", "openfda": {}, "recalling_firm": "CTV Best Group", "recall_number": "D-1154-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65900", "termination_date": "20150129", "recall_initiation_date": "20130801", "postal_code": "30096", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021992"], "brand_name": ["PRISTIQ"], "generic_name": ["DESVENLAFAXINE SUCCINATE"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "product_ndc": ["0008-1210", "0008-1211", "0008-1222"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DESVENLAFAXINE SUCCINATE"], "rxcui": ["790267", "790290", "1607617", "1607619", "1874553", "1874559"], "spl_id": ["1bdeb7f1-3871-48b2-9fa9-7fdb714faf3f"], "spl_set_id": ["0f43610c-f290-46ea-d186-4f998ed99fce"], "package_ndc": ["0008-1211-50", "0008-1211-01", "0008-1211-14", "0008-1211-30", "0008-1222-01", "0008-1222-14", "0008-1222-30", "0008-1222-50", "0008-1210-30"], "is_original_packager": [true], "upc": ["0300081210306", "0300081222309", "0300081211303"], "unii": ["ZB22ENF0XR"]}, "product_type": "Drugs", "event_id": "68001", "recalling_firm": "Pfizer Us Pharmaceutical Group", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1409-2014", "product_description": "Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc.,  NDC 0008-1211-30", "product_quantity": "220,761 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.", "recall_initiation_date": "20140416", "center_classification_date": "20140624", "termination_date": "20160920", "report_date": "20140702", "code_info": "H74477, H74478, Exp. 03/16,  H74479, H79766 Exp. 05/16"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU may be potentially mislabeled as    MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD46257_56, EXP: 5/15/2014;  MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD30028_28, EXP: 5/7/2014;  CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: AD60240_11, EXP: 5/22/2014.", "address_2": "", "product_quantity": "700 Capsules", "code_info": "LACTOBACILLUS ACIDOPHILUS Capsule, 500 Million CFU has the following codes    Pedigree: AD46257_28, EXP: 5/15/2014;  Pedigree: AD30028_10, EXP: 5/7/2014;  Pedigree: AD60240_20, EXP: 5/22/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS ACIDOPHILUS Capsule, 500 Million CFU, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 43292050022", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-560-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.", "address_2": "", "product_quantity": "438,055 bottles", "code_info": "Lot Numbers:    NDC 0603-9063-54 (120 mL):  L081K12A, exp. 4/14; L082K12A, exp. 4/14; L062M12A, exp. 6/14; L063M12A, exp. 6/14; L064M12A, exp. 6/14; L054A13A, exp. 7/14; L055A13A, exp. 7/14; L057A13A, exp. 7/14; L058A13A, exp. 7/14; L075B13A, exp. 8/14; L076B13A, exp 8/14; L003C13A, exp. 8/14; L004C13A, exp. 8/14; and L005C13A, exp. 8/14    NDC 0603-9063-58 (480 mL):  L081K12B, exp. 4/14; L082K12B, exp. 4/14; L059A13A, exp. 7/14; L114E13A, exp. 10/14; L026G13A, exp. 12/14; and L081J13A, exp. 3/15.", "center_classification_date": "20131231", "distribution_pattern": "Nationwide and Puerto Rico", "state": "AL", "product_description": "Cetirizine Hydrochloride Syrup (Cetirizine Hydrochloride Oral Solution, USP) 1 mg/mL, 120 mL and 480 mL bottles, Rx only. Mfg. for: Qualitest Pharmaceuticals, Huntsville, AL 35811. NDC 0603-9063-54 (120 mL), NDC 0603-9063-58 (480 mL).", "report_date": "20140108", "classification": "Class III", "openfda": {}, "recalling_firm": "Qualitest Pharmaceuticals", "recall_number": "D-394-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67102", "termination_date": "20141007", "more_code_info": "", "recall_initiation_date": "20131216", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; FOSINOPRIL SODIUM, Tablet, 20 mg may be potentially mislabeled as    TOLTERODINE TARTRATE ER, Capsule, 2 mg, NDC 00009519001, Pedigree: AD65478_1, EXP: 5/29/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "FOSINOPRIL SODIUM, Tablet, 20 mg has the following code    Pedigree: AD70690_1, EXP: 5/29/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "FOSINOPRIL SODIUM Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505251102", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-658-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DILTIAZEM HCL ER Capsule, 240 mg may be potentially mislabeled as    NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 37205098769, Pedigree: AD52433_4, EXP: 5/17/2014;  PARoxetine HCl, Tablet, 10 mg, NDC 13107015430, Pedigree: AD52778_67, EXP: 5/20/2014.", "address_2": "", "product_quantity": "180 Capsules", "code_info": "DILTIAZEM HCL ER, Capsule, 240 mg has the following codes    Pedigree: AD52375_1, EXP: 5/17/2014;  Pedigree: AD56917_1, EXP: 5/21/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DILTIAZEM HCL ER Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 49884083109", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-589-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 175 mcg may have potentially been mislabeled as the following drug:  CINACALCET HCL, Tablet, 60 mg, NDC 55513007430, Pedigree: W003742, EXP: 6/26/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 175 mcg has the following codes:   Pedigree: W003743, EXP: 6/26/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 175 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074707090.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-811-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019386"], "brand_name": ["BREVIBLOC"], "generic_name": ["ESMOLOL HYDROCHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["10019-055", "10019-115", "10019-075"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ESMOLOL HYDROCHLORIDE"], "rxcui": ["979432", "979434", "1736541", "1736543", "1736546", "1736547"], "spl_id": ["ff209fbb-f087-4772-8945-9b1ab9a8c3a2"], "spl_set_id": ["595cc3d5-1306-4828-aefa-5595219ffd62"], "package_ndc": ["10019-115-39", "10019-115-01", "10019-075-87", "10019-055-61"], "is_original_packager": [true], "unii": ["V05260LC8D"]}, "product_type": "Drugs", "event_id": "68577", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1413-2014", "product_description": "Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.", "product_quantity": "20,810 containers", "reason_for_recall": "Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.", "recall_initiation_date": "20140616", "center_classification_date": "20140701", "termination_date": "20170410", "report_date": "20140709", "code_info": "Lot #: C926923, Exp 01/16", "more_code_info": ""}]